can semaglutide cause seizures and Epilepsy: Safety, Seizure Risk, Provider Guidance – PlexusDx Could GLP-1 Drugs Lower Epilepsy

receives funding from Novo Nordisk and has received speaking fees from Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Merck, AstraZeneca, Mercodia and Berlin Chemie AG

These molecules can trigger the release of two hormones linked to curbing hunger: GLP-1 and PYY (peptide YY)

The prolong use of certain gut peptides such as PYY3-36 and GLP-1, seems to be rational, particularly, that the deficiency of these peptides in obesity has been documented (95)

Over recent years, however, significant advances in oral drugs for weight loss have made the treatments more accessible

People who may be at risk of misusing semaglutides should talk to their doctor about alternatives for achieving sustainable weight loss

Through expert opinions and patient experiences, we consider the need for responsible prescribing, improved education and equitable access for those who could benefit from Ozempic, Wegovy and other GLP-1 therapies